[18F]-Fluoroestradiol PET/CT: a modern look at nuclear medicine applications

Breast cancer is one of the most commonly diagnosed cancers and the leading cause of cancer mortality among women. Approximately 70–80 % of breast cancers are estrogen (ER) and/or progesterone receptor-positive, thus making endocrine therapy an important stage of treatment. Receptor expression in br...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: A.   V. Parnas, A.   I. Pronin, V.  S.  Ilyakov, N.   A. Meshcheryakova, Z.  Kh.  Kamolova, A.  I.  Mikhaylov
Aineistotyyppi: Artigo
Kieli:Russo
Julkaistu: ABV-press 2021-06-01
Sarja:Opuholi Ženskoj Reproduktivnoj Sistemy
Aiheet:
pet/ct
18f-fdg
18f-fes
estrogen receptors
breast cancer
Linkit:https://ojrs.abvpress.ru/ojrs/article/view/810
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia